Pfizer boosts full-year guidance on the back of its latest quarter, citing growth in non-Covid offerings and acquired ...
Pfizer CEO Albert Bourla says the company can replicate its past success as it leads a renewed push into the weight-loss drug ...
CNBC’s Annika Kim Constantino and Albert Bourla, Pfizer CEO, join 'The Exchange' to discuss Pfizer's Q3 earnings, patent ...
CNBC’s Annika Kim Constantino and Albert Bourla, Pfizer CEO, join 'The Exchange' to discuss Pfizer's Q3 earnings, patent ...
Pfizer, historically one of the biggest dealmakers in pharma, is out of the game—for now. CEO Albert Bourla said the company ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Custom Feed: See the stories that matter most to you. Smart Alerts: Get notified about major news as it happens. Update ...
Pharmaceutical company Pfizer is touting its collaboration with the first Trump administration to rapidly produce one of the major Covid-19 vaccines, as the Trump administration has sewn doubt about ...
The patent-expiry question is still open: whether cutting costs now buys enough time for late-stage trials to replace fading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results